CUSIP 92532F100COMVRTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
1,628 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Capital World Investors | 25.51M | $11.57B | −400.4K | Reduced |
| 2 | Vanguard Group Inc | 24.11M | $10.93B | −111.0K | Reduced |
| 3 | Blackrock, Inc. | 23.75M | $10.77B | +1.50M | Added |
| 4 | Capital Research Global Investors | 17.32M | $7.85B |
| +763.1K |
| Added |
| 5 | State Street Corp | 11.69M | $5.30B | +83.5K | Added |
| 6 | Jpmorgan Chase & Co | 6.04M | $2.74B | −395.3K | Reduced |
| 7 | Geode Capital Management, LLC | 5.98M | $2.70B | +8.2K | Added |
| 8 | Capital International Investors | 4.73M | $2.15B | +44.5K | Added |
| 9 | Alliancebernstein L.P. | 4.50M | $2.04B | −26.1K | Reduced |
| 10 | Loomis Sayles & Co L P | 4.03M | $1.83B | −88.6K | Reduced |
See every fund holding Vertex Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders